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ABSTRACT Small-angle x-ray scattering data on the unliganded full-length fully glycosylated HIV-1 gp120, the soluble CD4
(domains 1–2) receptor, and their complex in solution are presented. Ab initio structure restorations using thesedata provides the ﬁrst
look at the envelope shape for the unliganded and the complexed gp120molecule. Fitting known crystal structures of the unliganded
SIVand the complexedHIVgp120core regionswithin our resultant shapeconstraints revealsmovement of theV3 loopuponbinding.
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The binding of HIV-1 and SIV gp120 to its receptor
(CD4) and coreceptor on the host cell surface initiates the
viral fusion and entry process. Structures of the complex of
HIV-1 gp120 core with the soluble CD4 (sCD4) receptor
(1,2), of the unliganded SIV gp120 core (3,4), and of the V3-
containing HIV-1 gp120 core cocomplexed with both sCD4
and X5 antibody (4) have been solved. The ‘‘core’’ region of
the HIV gp120 protein, for which crystal structures are
known, lacks N- and C-terminal extensions, three variable
(V1-V3) loops, and glycosylation (;50%). These loop
regions play an important role in molecular recognition and
have been the limiting factor in resolving the crystal structure
of the full-length gp120 molecule (1–5). Placement of the
stem residues for the missing loops within the known struc-
tures imply signiﬁcant conformational changes within gp120
during complex formation. We used solution small-angle
x-ray scattering (SAXS) on the full-length HIV-1 gp120,
sCD4 (D1-D2), and their 1:1 complex under native-like con-
ditions to model the individual components and the resultant
shape changes upon complexation.
The proteins, gp120 and sCD4, were gifted by the National
Institutes of Health Research and Reference Reagent Pro-
gram. SAXS data were collected at beam line X21 at National
Synchrotron Light Source (Brookhaven National Labora-
tory). The wavelength of the beamwas 1.24 A˚ and the ratio of
the sample/detector distance to the diameter of the charge-
coupled device detector (D/d) was 9.94M. Samples (30ml) of
the individual proteins, their complex, and phosphate buffer
saline pH 7.4 were exposed for 60 s, each at 10C and at a
ﬂow-rate of 27 mL/min. SAXS data collected at several
concentrations of hen egg white lysozyme (14.2 kDa;
ACROS, Morris Plains, NJ) were run in the same sample
cell under identical conditions. Images were circularly
averaged, buffer-subtracted, and scaled to obtain relative
scattering intensity (I) as a function of q (reciprocal space, q¼
[4psinu]/l). All experiments were carried out in duplicate.
Guinier analysis, using PRIMUS (6), illustrate a linear ﬁt
to the unliganded gp120 data (Fig. 1 A, inset), the sCD4 data
(Fig. 1 C, inset), and the SAXS data of their mixture (Fig. 2
A, inset) over the expected q range (where qmax  Rg # 1).
This analysis demonstrates monodispersity of scattering
particles in solution. An indirect Fourier transform of the
SAXS data, using GNOM45 (7), gave the pairwise distance
distribution function in real space, P(r). The beam intensity
at zero-angle (I0) determined from GNOM analysis of the
lysozyme data, which had been extrapolated to inﬁnite
dilution, was measured at 9.7 6 0.1. This value was used
to calculate the concentrations of the individual proteins
(0.95 mg/ml of gp120 and 1.25 mg/ml of sCD4). A 1.3:1
molar mixture of sCD4/gp120 was made by adding 10 ml of
sCD4 (46 mM) to 47 ml of gp120 (7.8 mM). I0 analysis of this
mixture predicts that 73% of the proteins had formed a 1:1
complex under these conditions. Assuming formation of a
complete 1:1 complex, actual protein concentration for the
gp120/sCD4 complex would be maximum 0.95 mg/ml
(6.5 mM), leaving 1.73 mM (0.04 mg/ml) of sCD4
uncomplexed in solution. (The uncomplexed sCD4 would
contribute only 1.8% to the scattering from the mixture). P(r)
analysis of the gp120 data (Fig. 1 B) solves for an Rg of 43.6
A˚ and aDmax of 166 A˚. Indirect Fourier transformation of the
sCD4 data over a q range of 0.01–0.25 A˚1 solves for an Rg
of 22.3 A˚ and a Dmax of 75 A˚ (Fig. 1 D). This P(r) curve
exhibits a peak and a shoulder indicative of the expected
bilobal shape for the two domains of sCD4. P(r) analysis of
the SAXS data for the mixture (q range of 0.01–0.25 A˚1)
solves well for an Rg of 44.4 A˚ with a Dmax of 165 A˚ (Fig. 2
B). Values for the I0, Rg, and Dmax determined from the
SAXS data analysis are summarized in Table 1.
GASBOR22IQW (8) was employed for ab initio shape
restorations, whereby the protein structure is represented by
an ensemble of dummy residues forming a chain-compatible
model and tested for best ﬁt to the I(q) scattering data. The
models of unliganded gp120, sCD4, and their complex used
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2168, 298, and 2387 dummy residues (packing radius 1.9 A˚
each), and 1598, 234, and 1598 dummy water molecules,
respectively. Each calculation was repeated 10 times, with
no shape or symmetry bias (Supplementary Figs. 1–3). For
each data set modeled, one representative shape restoration
model was selected based on the frequency of occurrence of
the major shape features and are shown in Figs. 3 and 4.
The shape of the gp120 molecule in solution is charac-
terized by a dense central core and less dense regions on
three sides of the core region (Fig. 3 A). Using SUPCOMB13
(9), inertial axes of this gp120 model were overlapped with
those for the unliganded SIV gp120 core (Protein Data Bank
(PDB) No. 2BF1) (3). The automated superposition of high-
and low-resolution models show that SIV gp120 core resides
within the dense region of our model (Fig. 3 B). SAXS-based
model of unliganded gp120 thus displays the volume, which
the variable domains as well as high levels of glycosyla-
tion must be occupying in solution. The SIV gp120 protein
(44.3 kDa) used for the crystal structure has ;65% smaller
molecular weight than that used in our solution studies. Ab
initio structure restoration for sCD4 (Fig. 3 C) clearly shows
the expected low density between the two domains, also seen
in the shape of the P(r) plot. Overlapping the inertial axes of
our scattering envelope with those for the unliganded sCD4
(D1-D2) (PDB No. 3CD4) (10) showed excellent agreement
in shape and size between the two models (Fig. 3 D).
FIGURE 1 SAXS data (A) and P(r) plot (B) for unliganded full-
length HIV-1 gp120. SAXS data (C) and P(r) curve (D) for the
uncomplexed CD4 (D1-D2 domains). Linear ﬁts from the Guinier
analysis of these data are shown in the insets.
FIGURE 2 (A) SAXS data for the 1.3:1 mixture of sCD4/gp120.
Inset shows the linearity of the Guinier plot. (B) A comparison of
the P(r) curves calculated from the SAXS data for the unliganded
gp120 (red), sCD4 (purple), and their mixture (blue).









(mg/ml) Rg (A˚) Dmax (A˚)
Lysozyme 14.2 9.7 – 1 14.6 45
gp120 120 77.5 82.0 0.95 42.4 166
sCD4 26 21.6 17.8 1.25 22.3 75
1:1 146 88.2 95.4 0.88 44.4 165
complex
The q range input for each analysis was from 0.01 to 0.25 A˚1.
FIGURE 3 Scattering envelopes of (A) the full-length unli-
ganded gp120 molecule with all dummy residues (red) shown
in space-ﬁll mode. (B) Two orthogonal views of the superimpo-
sition of inertial axes of our SAXS model (transparent, red) and
the crystal structure of glycosylated SIV core, PDB No. 2BF1
(purple ribbon). (C) Space-ﬁlled representation (purple) of the
scattering envelope that best ﬁt the sCD4 SAXS data. (D) Two
views of the sCD4 model (transparent, purple) superimposed
with the crystal structure (red ribbon) of unliganded CD4, PDB
No. 3CD4.
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The scattering envelope computed for the sCD4/gp120
SAXS data (Fig. 4 A) reveals three distinct features: the
bilobal shape of the two domains of sCD4, a densely packed
region over the top of one lobe of sCD4, and a less dense
region that corresponds to the gp120 glycoprotein. The
envelope volume is 303,000 A˚3, which agrees well with the
sum total envelope volumes calculated for the individual
components (25,900 and 276,000 A˚3), indicating that ﬂexi-
bility does not change considerably upon binding. Align-
ment of inertial axes of only the sCD4 domains from the
crystal structures (PDBNos. 1G9M and 1GC1) with the small
bilobal arm protrusion in our SAXS-based model places the
gp120 core structure from the crystal structures within the
dense region of our model (Fig. 4 C). The additional volume
around two sides of D1 domain in complex could be arising
from the b-strands of gp120 core clamping that lobe as in
1GC1 or 1G9M (1,2). Comparing Fig. 4, B and C, it is clear
that the binding of gp120 core to the apex of D1 domain of
CD4 drastically reorients the less dense regions of gp120 not
seen previously in crystal structures containing only the
cores.
Our SAXS data provide structural constraints for model-
ing the interaction between the viral envelope protein of
HIV-1 and its host cell receptor CD4. We propose that the
small lobe sticking out (;30 A˚) from the unliganded protein
is likely to be the V3 loop of gp120. The small orange
volume (Fig. 4 C) depicts the four residues where the V3
loop would have been connected in the crystal structures
1G9M or 1GC1. Assuming that this ‘‘lobe’’ does represents
the V3 loop, then binding to CD4 induces this loop to stick
out away from the compact core, even in the absence of a
coreceptor. This suggestion is exempliﬁed by an increased
exposure (;38 A˚) and considerable movement of the small
‘‘V3’’ lobe away from the CD4/gp120 binding interface
(Fig. 4 C, right side).
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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FIGURE 4 (A) Two views of the
best-ﬁt model of the 1:1 complex
between full-length HIV-1 gp120
and sCD4 in solution. Dummy res-
idues (blue) are shown in space-ﬁll
mode. (B) SAXS-based models of
unliganded gp120 (red) and sCD4
(purple). (C) Two views of gp120
core (pink ribbon) and sCD4 (yel-
low ribbon) crystal structures, ex-
tracted from PDB No. 1G9M ﬁt
within the best-ﬁt model of the
SAXS data on the complex (trans-
parent, blue).
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